Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants
- PMID: 29374049
- PMCID: PMC5850242
- DOI: 10.1161/JAHA.117.007338
Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants
Keywords: anticoagulant; anticoagulation; apixaban; betrixaban; dabigatran; edoxaban; rivaroxaban; warfarin.
References
-
- Schofield FW. Damaged sweet clover; the cause of a new disease in cattle simulating haemorrhagic septicemia and blackleg. J Am Vet Med Assoc. 1924;64:553–556.
-
- Verstraete M, Prentice CR, Samama M, Verhaeghe R. A European view on the North American fifth consensus on antithrombotic therapy. Chest. 2000;117:1755–1770. - PubMed
-
- Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:160S–198S. - PubMed
-
- Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–352. - PubMed
-
- Andersen LV, Vestergaard P, Deichgraeber P, Lindholt JS, Mortensen LS, Frost L. Warfarin for the prevention of systemic embolism in patients with non‐valvular atrial fibrillation: a meta‐analysis. Heart. 2008;94:1607–1613. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical